Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 62/673,704, filed May 18, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,522,868 | Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization In force · High confidence | Twist Bioscience Corporation | In force | High confidence | ||
| US 11,492,665 | Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization In force · High confidence | Twist Bioscience Corporation | In force | High confidence | ||
| US 11,732,294 | Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization In force · High confidence | Twist Bioscience Corporation | In force | High confidence | ||
| Application 19/409,038 | Polynucleotides, Reagents, and Methods for Nucleic Acid Hybridization Pending Not granted | Twist Bioscience Corporation | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Twist Bioscience Corporation.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.